A larger body mass index is associated with increased atherogenic dyslipidemia, insulin resistance, and lowgrade inflammation in Individuals with Metabolic Syndrome - Ebron, K; Andersen, C J; Aguilar, D (Metab Syndr Relat Disord, 2015)
doi: 10.1089/met.2015.0053